Calamos Advisors
IQMDU

Calamos Advisors’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Calamos Advisors’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,250,000
Closed -$12.6M – 1446
2022
Q3 		$12.6M Hold
1,250,000
– – 0.06% 387
2022
Q2 		$12.5M Hold
1,250,000
– – 0.05% 414
2022
Q1 		$12.6M Hold
1,250,000
– – 0.05% 447
2021
Q4 		$12.8M Buy
+1,250,000
New +$12.7M 0.05% 413

Other funds holding IQMDU

YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Bracebridge Capital LLC
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Cubist Systematic Strategies
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Calamos Advisors's IQMDU Position: Q4 2022 in Review

Calamos Advisors sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q4 2022, closing a stake of 1,250,000 shares — an estimated $12.6M sold.

Calamos Advisors first reported a position in IQMDU in Q4 2021 and held it in 4 quarters. The position peaked at $12.8M in Q4 2021. 13 funds tracked by Wall St. Rank hold IQMDU as of Q4 2022.

  • Calamos Advisors reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
  • Calamos Advisors sold 1,250,000 Intelligent Medicine Acquisition Corp. Unit shares in Q4 2022, an estimated $12.6M.
  • Calamos Advisors first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
  • Calamos Advisors's Intelligent Medicine Acquisition Corp. Unit position peaked at $12.8M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q4 2022.

Based on Calamos Advisors's 13F filing for Q4 2022, filed 26 Jan 2023.